International law firm McDermott Will & Emery represented Hidden Harbor Capital Partners, a Florida-based private equity firm, in its sale of Cloyes Gear & Products, a leading manufacturer and distributor of aftermarket automotive parts, to MidOcean Partners V, L.P, a New York-based alternative asset manager specializing in middle-market private equity and alternative credit investments.

• The transaction was announced on February 22, 2022.
• The McDermott team was led by Fred Levenson, Alex Clavero, Lindsey Reighard, Karla Utset and Daniel Fernandez and included Alex Ruiz, Emily Mussio, Sarah Bro, Allison Wilkerson, Rick Stepanovic, Gregg Fierman, Kate Williams, Michelle Strowhiro, Christopher Foster, Michael Boykins, Greg Heltzer and David Saunders.
• Read MidOcean Partners’ press release.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

International law firm McDermott Will & Emery represented funds managed by Kayne Anderson Capital Advisors, L.P. (Kayne Anderson), a leading alternative investment management firm focused on real estate, credit, infrastructure/energy, renewables and growth equity, in a $182.5 million equity commitment to TreadStone Energy Partners III, LLC (TreadStone III), a private exploration and production company formed to pursue, acquire and exploit opportunities with scalable exploitation and development upside.

• The transaction closed on January 24, 2022.
• This transaction allowed Kayne Anderson to upsize and restructure an equity commitment to TreadStone III, providing additional capital to TreadStone III, a highly successful repeat management team of Kayne Anderson.
• The McDermott team was led by Kevin Brophy and Jack Langlois and included Jibin Luke, Adam Sherman, William Pomierski and Sarah Nabors.
• Read Kayne Anderson’s press release.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

International law firm McDermott Will & Emery represented Anderson Holdings, a private, family-owned, diversified holding company headquartered in Los Angeles with operations across Southern California, Hawaii and the U.S. and British Virgin Islands, in the equity and asset sale of its wholesale beverage distribution business in the U.S. and British Virgin Islands to Clare Holdings LLC, of Illinois, a diversified group of companies with a strong footprint in the Caribbean through its Merchants Market food and related products distribution network. This sale by Anderson Holdings includes the brands Bellows International, West Indies Company, Prestige Wine Group, Leeward Islands Management Company and Caribbean Cellars, Ltd.

• The transaction closed on February 18, 2022.
• The McDermott team was led by Michael Halsband, Anne Cox-Johnson, and Thaddeus Chase Jr. and included Erin Turley, Carole Spink, Raja Chatterjee, John Lutz, Andrew Granek, Lesli Esposito, Matt Evola and David Neville.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

International law firm McDermott Will & Emery represented Merck KGaA, Darmstadt, Germany, a leading science and technology company, through its subsidiary Ares Trading S.A., in a venture-capital style investment in and its licensed spinoff of global intellectual property rights for a regenerative monoclonal antibody known as “Sprifermin”, being investigated to treat osteoarthritis, to High Line Bio, Inc., a new US-based company formed for this purpose by TrialSpark, which uses its tech-enabled platform to run end-to-end clinical trials.

• The transaction was announced on January 10, 2022.
• This transaction continues the strategic evolution of Merck KGaA, Darmstadt, Germany’s  immunology pipeline.  McDermott also represented it in earlier spinoffs to the US, for example, of assets to address inflammatory and progressive aspects of multiple sclerosis within the central nervous system, and autoimmune kidney disease.
• The McDermott team was led by Albert Sokol and included Jennifer Bock, Rebecca Dufur, Robert Cohen, David Levine, Michael Bruno, Keith Hagan and Michael Wilder.
• Read Merck KGaA, Darmstadt, Germany’s press release.

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany, generated sales of € 17.5 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.